Regucalcin in proximal tubule epithelial kidney cells (Homo sapiens)

From WikiPathways

Revision as of 06:58, 2 May 2020 by Egonw (Talk | contribs)
Jump to: navigation, search
31Leads to/ stimulates Apoptosis Renal cell homeostasisAutophagy Ligand Cell proliferatie Legend Mineral ion transport protein gene expressionCell proliferation proteinsApoptosis proteins (e.g. p53)IL-8 expressionStimulationDNA fragmentationRepresents the receptor InhibitionRenal fibrosis Apical (lumen)BasolateralBinding Degradation ConversionProtein synthesis MicrosomeUbiquitinationCell growth/ differentation Lanthanum chlorideTrifluoperazineDAGPIP2SMAD4IP3FFAR3PTHNOS1MAP3K5AKT1Nitric oxide signalingCASP3SLC8A1Cytochrome CAMPMTOR3Na+PPP3R1TNFSF11CASP8Bcl-2PTPNF1NR3C2TNFAPSP PRKACARuthenium redPRKCQMAPK10ROSRGNNOPMATNFRSF1ACALCACASP9TRPV5RAF1MEKMAP2K1APAF1SEC16BSMAD2PPP3R1TGFBR1MAPK1PDE1BMAPK3DiacylglycerolCytochrome CL-arginineTGFB1BRAFcAMPROS1RELACalmodulinATP2B3G3BP1ACTA2BAXAldosteroneSENP8PI3K3CABAK1MCU2Ca2+Bcl-2RGNCa2+Ca2+Ca2+Ca2+Ca2+MCUCa2+AldosteroneCytoplasmic mineralocorticoid receptor RGN Ca2+3Na+MCUCalmodulinCa2+Ca2+ROSCa2+Cytochrome CBcl-2Ca2+


This pathway includes the proximal tubule epithelial kidney cells (NRK52E cell) with a basolateral and apical side and other schematic illustrated organelles involved in the process of kidney function. The influence of regucalcin on the intra-and extracellular Ca2+ regulation is showed which are both involved in cell proliferation, ion transport and apoptosis and are important in normal kidney function. When the regulation of regucalcin and other factors are downregulated and suppressed, the kidney fails in functionality and so renal fibrosis will develop.

First of all, TGF-B (TGFB1) and TNF-a (TNFA) do have an impact on the activity of SMAD2/4 which has an impact on the development of a-SMA (ACTA2) that induced renal fibrosis. NF-kB (TNFSF11), stimulated by TNF-a, activates the transcription factor p65 (RELA) that induced the IL-8 expression which is involved in inflammatory pathways. On the other hand, regucalcin inhibits the a-SMA which means that the formation of renal fibrosis is inhibited. Further, TGF-B stimulates the caspase 8 (CASP8) that activates the cytochrome C which activate the apoptosis pathway. Also, here regucalcin function as an inhibitor for APAF1 that results in an inhibition of the apoptosis pathway and activate the BCL-2 (suppressor of apoptotic cell death). Besides the TGF-B and TNF-a pathway, there is an RTK pathway illustrated which activates the PI3K (PI3K3CA) and RAS (G3BP1) pathway for stimulation of the renal homeostasis, autophagy, protein and cell proliferation. According to Yamaguchi M. (2015), regucalcin activates the AKT1 to induce the renal homeostasis, autophagy and protein proliferation even further when PI3K is inhibited. The RTK pathway shows interaction with the cAMP pathway that stimulate the protein kinase A (PRKACA) and the PIP2 pathway that stimulate the protein kinase C (PRKCQ) and IP3. These all will stimulate Ca2+ release from the endoplasmic reticulum (ER). This Ca2+ can migrate and enters the mitochondria through the Ca2+ uniporter (MCU) which results in the activation of mitochondrial biological processes or release of different mitochondrial factors. Hence, calcium controls and modulate cell apoptosis and inflammation. MAP3K pathway might be involved in the stimulation of RAF1 to induce the cell proliferation and the increase in apoptosis by inhibition of BCL-2 through JNK (MAPK10) which is also activated by ROS. Ca2+ released by the ER can also bind to calmodulin to form the Ca2+/Calmodulin complex that stimulates IP3, JNK, NOS, RGPR—p117 (SEC16B) and NF1. The latter two proteins are involved in the enhancement of regucalcin gene expression. On the other hand, regucalcin can inhibit the activity of Ca2+/Calmodulin complex and the NOS. Normally, phosphodiesterase (PDE1B) binds cAMP that induced the degradation of cAMP which results in a decrease of protein kinase A that leads to a reduction of ER Ca2+ release. Regucalcin inhibits the phosphodiesterase in such a way that cAMP will not be degraded and the ER Ca2+ release can further occur. Remaining Ca2+ released from the ER can also transport to the microsomes, enters vis Ca2+ uniporter, to induce microsomal activities. This process of microsomal Ca2+ uptake can be diminished through the inhibition of IP3 kinase. Regucalcin is not only involved in the regulation of intracellular Ca2+ release or uptake, but also extracellular Ca2+ by stimulating the Ca2+/ATPase (ATP2B3) which leads to Ca2+ export. Besides that, the Na+/Ca2+ exchanger (SLC8A1) is important to be present on the basolateral membrane of the proximal tubule epithelial kidney cell to regulate the ion transport. On the apical membrane is the TRPV5 receptor present that regulate the import of Ca2+ from the lumen back into the kidney cell, but Ca2+ can also travel via paracellular transport. Further, in the nucleus the regucalcin has an influence on the inhibition of the serine/threonine phosphate (PSP), tyrosine phosphatase (PTP) and calcineurin (PPP3R1) gene expression. Normally, PSP stimulates the protein kinase A- and so the ER Ca2+ release-, PTP stimulates the cell growth and differentiation and calcineurin will migrate to the cytoplasm for binding to the Ca2+ and stimulates the formation of Ca2+/Calmodulin complex. In general, regucalcin regulates the factors and proteins involved in ion transport, cell proliferation and apoptosis. Research is done on rats.

Quality Tags

Ontology Terms



  1. Fantus D, Rogers NM, Grahammer F, Huber TB, Thomson AW; ''Roles of mTOR complexes in the kidney: implications for renal disease and transplantation.''; Nat Rev Nephrol, 2016 PubMed Europe PMC Scholia
  2. Li J, Jia Z, Zhou W, Wei Q; ''Calcineurin regulatory subunit B is a unique calcium sensor that regulates calcineurin in both calcium-dependent and calcium-independent manner.''; Proteins, 2009 PubMed Europe PMC Scholia
  3. Yamaguchi M; ''The potential role of regucalcin in kidney cell regulation: Involvement in renal failure (Review).''; Int J Mol Med, 2015 PubMed Europe PMC Scholia


View all...
110282view07:54, 2 May 2020EgonwNot a mim-conversion
110274view06:58, 2 May 2020EgonwReplaced secondary ChEBI identifiers with a primary identifiers.
110237view15:13, 29 April 2020EgonwNot a mim-conversion
110193view17:55, 23 April 2020EgonwReplaced old Uniprot data source names by the currently used one.
109321view15:10, 11 March 2020P.vanLierModified description
109320view15:07, 11 March 2020P.vanLierModified description
109319view11:51, 11 March 2020FehrhartGraphical adjustment
109318view11:50, 11 March 2020FehrhartUpdated ID for TGFB1
109317view11:43, 11 March 2020FehrhartConversion of interaction in legend to graphical line
109300view13:02, 6 March 2020P.vanLierModified description
109299view12:57, 6 March 2020P.vanLierModified description
109298view12:55, 6 March 2020P.vanLierModified description
109297view12:53, 6 March 2020P.vanLierModified description
109296view12:51, 6 March 2020P.vanLierModified title
109295view12:50, 6 March 2020P.vanLierModified description
109294view12:41, 6 March 2020P.vanLierModified description
109278view10:51, 4 March 2020P.vanLierModified description
109277view10:50, 4 March 2020P.vanLierNew pathway

External references


View all...
NameTypeDatabase referenceComment
3Na+MetaboliteCHEBI:26708 (ChEBI)
ACTA2GeneProductENSG00000107796 (Ensembl)
AKT1GeneProductENSG00000142208 (Ensembl)
AMPMetaboliteCHEBI:16027 (ChEBI)
APAF1GeneProductENSG00000120868 (Ensembl)
ATP2B3ProteinQ64568 (Uniprot-TrEMBL)
AldosteroneMetaboliteCHEBI:27584 (ChEBI)
BAK1GeneProductENSG00000030110 (Ensembl)
BAXGeneProductENSG00000087088 (Ensembl)
BRAFGeneProductENSG00000157764 (Ensembl)
Bcl-2MetaboliteCHEBI:133022 (ChEBI)
CALCAProteinP01258 (Uniprot-TrEMBL)
CASP3ProteinP42574 (Uniprot-TrEMBL)
CASP8ProteinENSG00000064012 (Ensembl)
CASP9ProteinENSG00000132906 (Ensembl)
Ca2+MetaboliteCHEBI:22984 (ChEBI)
CalmodulinMetaboliteCHEBI:3324 (ChEBI)
Cytochrome CMetaboliteCHEBI:18070 (ChEBI)
Cytoplasmic mineralocorticoid receptor ProteinP22199 (Uniprot-TrEMBL)
DAGMetaboliteCHEBI:41847 (ChEBI)
DiacylglycerolMetaboliteCHEBI:18035 (ChEBI)
FFAR3ProteinA0A0K0PUW7 (Uniprot-TrEMBL)
G3BP1ProteinQ5U0Q1 (Uniprot-TrEMBL)
IP3MetaboliteCHEBI:16595 (ChEBI)
L-arginineMetaboliteCHEBI:32682 (ChEBI)
Lanthanum chlorideMetaboliteQ421212 (Wikidata)
MAP2K1ProteinQ01986 (Uniprot-TrEMBL)
MAP3K5ProteinQ99683 (Uniprot-TrEMBL)
MAPK10ProteinP49187 (Uniprot-TrEMBL)
MAPK1GeneProductENSG00000100030 (Ensembl)
MAPK3ProteinP21708 (Uniprot-TrEMBL)
MCUProteinQ8NE86 (Uniprot-TrEMBL)
MEKMetaboliteCHEBI:28398 (ChEBI)
MTORGeneProductENSG00000198793 (Ensembl)
NF1ProteinP97526 (Uniprot-TrEMBL)
NOMetaboliteCHEBI:16480 (ChEBI)
NOS1ProteinB3VK56 (Uniprot-TrEMBL)
NR3C2ProteinP22199 (Uniprot-TrEMBL)
Nitric oxide signalingMetaboliteCHEBI:16480 (ChEBI)
PDE1BProteinA0A024RB59 (Uniprot-TrEMBL)
PI3K3CAProteinENSG00000121879 (Ensembl)
PIP2MetaboliteCHEBI:18348 (ChEBI)
PMAMetaboliteCHEBI:37537 (ChEBI)
PPP3R1ProteinENSG00000221823 (Ensembl)
PRKACAProteinP27791 (Uniprot-TrEMBL)
PRKCQProteinA0A087X0I9 (Uniprot-TrEMBL)
PSP MetaboliteCHEBI:31991 (ChEBI)
PTHGeneProductENSG00000152266 (Ensembl)
PTPMetaboliteCHEBI:52242 (ChEBI)
RAF1GeneProductENSG00000132155 (Ensembl)
RELAProteinA0A087WVP0 (Uniprot-TrEMBL)
RGN ProteinQ15493 (Uniprot-TrEMBL)
RGNProteinQ15493 (Uniprot-TrEMBL)
ROS1ProteinQ63132 (Uniprot-TrEMBL)
ROSMetaboliteCHEBI:26523 (ChEBI)
ROSMetaboliteCHEBI:70982 (ChEBI)
Ruthenium redMetaboliteCHEBI:34956 (ChEBI)
SEC16BProteinQ96JE7 (Uniprot-TrEMBL)
SENP8ProteinKW-0788 (Uniprot-TrEMBL)
SLC8A1ProteinQ01728 (Uniprot-TrEMBL)
SMAD2GeneProductENSG00000175387 (Ensembl)
SMAD4GeneProductENSG00000141646 (Ensembl)
TGFB1GeneProductENSG00000105329 (Ensembl)
TGFBR1ProteinP36897 (Uniprot-TrEMBL)
TNFAProteinP16599 (Uniprot-TrEMBL)
TNFRSF1AGeneProductENSG00000067182 (Ensembl)
TNFSF11ProteinENSG00000120659 (Ensembl)
TRPV5GeneProductENSG00000127412 (Ensembl)
TrifluoperazineMetaboliteCHEBI:45951 (ChEBI)
cAMPMetaboliteCHEBI:17489 (ChEBI)

Annotated Interactions

No annotated interactions

Personal tools